TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Focus Groups
KW - Humans
KW - Needs Assessment
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - implementation science
KW - medication-assisted treatment
KW - Office-based opioid treatment
KW - opioid use disorder
AU - A . Y. Truong
AU - B. F. Saway
AU - M. H. Bouzaher
AU - M. N. Rasheed
AU - S. Monjazeb
AU - S. D. Everest
AU - S. L. Giampalmo
AU - D. Hartman
AU - C. Hartman
AU - A. S. Kablinger
AU - R. L. Trestman
A1 - 
AB - BACKGROUND: Clinical trials provide consistent evidence for buprenorphine's efficacy in treating opioid use disorder (OUD). While the Drug Addiction Treatment Act of 2000 requires physicians to combine medication-assisted treatment (MAT) with behavioral intervention, there is no clear evidence for what form or elements of psychotherapy are most effective when coupled with MAT to treat OUD. This investigation involves focus groups designed to collect patient opinions about a specific psychotherapy, called START NOW, as well as general beliefs about various elements of psychotherapy for treating OUD. Our analysis reveals trends about patient preferences and strategies for improving OUD treatment. METHODS: Subjects included patients enrolled in buprenorphine/naloxone MAT at our institution's office-based opioid treatment program. All subjects participated in a single START NOW group session, which was led by a provider (physician or nurse practitioner trained and standardized in delivering START NOW). Consented subjects participated in satisfaction surveys and audio-recorded focus groups assessing individual beliefs about various elements of psychotherapy for treating OUD. RESULTS: Overall, 38 different focus groups, 92 participation events, and 44 unique subjects participated in 1-to-6 different START NOW session/audio-recorded focus group sessions led by a certified moderator. Demographic data from 36/44 subjects was collected. Seventy-five percent (33/44) completed the START NOW Assessment Protocol, which revealed self-reported behavioral trends. Analysis of all 92 START NOW Satisfaction Questionnaire results suggests that subjects' opinions about START NOW improved with increased participation. Our analysis of audio-recorded focus groups is divided into three subsections: content strategies for new psychotherapies, implementation strategies, and other observations. For example, participants request psychotherapies to target impulsivity and to teach future planning and build positive relationships. CONCLUSIONS: The results of this study may guide implementation of psychotherapy and improve the treatment of OUD, especially as it relates to improving the modified START NOW program for treating OUD. Our study also reveals a favorable outlook of START NOW with increased participation, suggesting that any initial reticence to this program can be overcome to allow for effective implementation.
AD - Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Carilion Clinic Psychiatry & Behavioral Medicine, 2017 S. Jefferson Street, 1st Floor Administrative Suite, Roanoke, VA, 24014, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Carilion Clinic Psychiatry & Behavioral Medicine, 2017 S. Jefferson Street, 1st Floor Administrative Suite, Roanoke, VA, 24014, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.; Carilion Clinic Psychiatry & Behavioral Medicine, 2017 S. Jefferson Street, 1st Floor Administrative Suite, Roanoke, VA, 24014, USA.; Virginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA. rltrestman@carilionclinic.org.; Carilion Clinic Psychiatry & Behavioral Medicine, 2017 S. Jefferson Street, 1st Floor Administrative Suite, Roanoke, VA, 24014, USA. rltrestman@carilionclinic.org.
BT - BMC psychiatry
C5 - Education & Workforce; Healthcare Policy; Measures; Opioids & Substance Use
CP - 1
DO - 10.1186/s12888-020-03024-x
IS - 1
JF - BMC psychiatry
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Clinical trials provide consistent evidence for buprenorphine's efficacy in treating opioid use disorder (OUD). While the Drug Addiction Treatment Act of 2000 requires physicians to combine medication-assisted treatment (MAT) with behavioral intervention, there is no clear evidence for what form or elements of psychotherapy are most effective when coupled with MAT to treat OUD. This investigation involves focus groups designed to collect patient opinions about a specific psychotherapy, called START NOW, as well as general beliefs about various elements of psychotherapy for treating OUD. Our analysis reveals trends about patient preferences and strategies for improving OUD treatment. METHODS: Subjects included patients enrolled in buprenorphine/naloxone MAT at our institution's office-based opioid treatment program. All subjects participated in a single START NOW group session, which was led by a provider (physician or nurse practitioner trained and standardized in delivering START NOW). Consented subjects participated in satisfaction surveys and audio-recorded focus groups assessing individual beliefs about various elements of psychotherapy for treating OUD. RESULTS: Overall, 38 different focus groups, 92 participation events, and 44 unique subjects participated in 1-to-6 different START NOW session/audio-recorded focus group sessions led by a certified moderator. Demographic data from 36/44 subjects was collected. Seventy-five percent (33/44) completed the START NOW Assessment Protocol, which revealed self-reported behavioral trends. Analysis of all 92 START NOW Satisfaction Questionnaire results suggests that subjects' opinions about START NOW improved with increased participation. Our analysis of audio-recorded focus groups is divided into three subsections: content strategies for new psychotherapies, implementation strategies, and other observations. For example, participants request psychotherapies to target impulsivity and to teach future planning and build positive relationships. CONCLUSIONS: The results of this study may guide implementation of psychotherapy and improve the treatment of OUD, especially as it relates to improving the modified START NOW program for treating OUD. Our study also reveals a favorable outlook of START NOW with increased participation, suggesting that any initial reticence to this program can be overcome to allow for effective implementation.
PY - 2021
SN - 1471-244X; 1471-244X
SP - 020
EP - x
EP - 23+
T1 - Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder
T2 - BMC psychiatry
TI - Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder
U1 - Education & Workforce; Healthcare Policy; Measures; Opioids & Substance Use
U2 - 33423661
U3 - 10.1186/s12888-020-03024-x
VL - 21
VO - 1471-244X; 1471-244X
Y1 - 2021
Y2 - Jan 10
ER -